{"id":"NCT01879618","sponsor":"Pfizer","briefTitle":"Use Of Fragmin In Hemodialysis","officialTitle":"A Phase IIIb Open Label Study To Optimize The Single Bolus Dose Of Dalteparin Sodium For The Prevention Of Clotting Within The Extracorporeal System During Hemodialysis Procedures For Subjects With Chronic Renal Insufficiency: The Parrot Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10","primaryCompletion":"2016-03","completion":"2016-03","firstPosted":"2013-06-18","resultsPosted":"2016-12-29","lastUpdate":"2017-03-10"},"enrollment":152,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Renal Failure"],"interventions":[{"type":"DRUG","name":"Fragmin","otherNames":[]}],"arms":[{"label":"Fragmin","type":"EXPERIMENTAL"}],"summary":"The study will determine if the Fragmin dose can be adjusted to suit the clinical needs of patients during dialysis.","primaryOutcome":{"measure":"Mean Percent of Successful HD Sessions","timeFrame":"20 HD sessions (up to 4 hours)","effectByArm":[{"arm":"FRAGMIN","deltaMin":99.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":19,"countries":["Canada"]},"refs":{"pmids":["30542622"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6301091&StudyName=Use%20Of%20Fragmin%20In%20Hemodialysis"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":152},"commonTop":["Arteriovenous fistula site haemorrhage","Hypotension"]}}